By the end of Module 10, you will be able to:
The purpose of Module 10 is to pull everything we have learned together, apply it, and practise it using one big case study. We will integrate what we have learned about the importance of data, using numeric indicators in quality improvement, calculating data summaries, and studying health problems using various study designs, and more!
Pre-test (10 minutes)
Part 1: Introduction (30 minutes)
Part 2: The Patient & Data Pathway (15 minutes)
Part 3: Monitoring, Evaluation, & Indicators (30 minutes)
Part 4: Quality Improvement (45 minutes)
Part 5: Applied Epidemiology (30 minutes)
In Part 1, we learned about some of the struggles patients face in taking IPT, and the challenges clinics have in implementing the treatment. We also learned about the national guidelines for IPT, and how they help prevent transmission of TB.
In Part 2, we reviewed the patient and data pathways for patients like Andiswa who are taking IPT.
In Part 3, we went through a scenario that allowed us to discuss indicators, treatment targets, and the types of monitoring and evaluation activities the Mzansi team should be doing with respect to IPT.
In Part 4, we used quality improvement processes to look at how Mzansi Clinic can increase IPT adherence among their patients.
In Part 5, we applied some epidemiology concepts to the IPT scenario. This module provided many opportunities along the way to practise and apply what you’ve learned about epidemiology.
Now, it is time for congratulations! You’ve completed Module 10, which means you’ve also completed the course!
Post-test (10 minutes)
Golub JE, Pronyk P, Mohapi L, et al. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. AIDS. 2009;23(5):631-6.